• Patients treated with tocilizumab for RA showed sustained improvements through second year

    8 days ago - By Healio

    According to recently published data, patients with rheumatoid arthritis treated with either tocilizumab as monotherapy or as a combination therapy with methotrexate sustained improvements from year 1 through year 2 and researchers found no new safety concerns. Gerd R. Burmester, MD, professor of medicine and clinical researcher at the Charit University Hospital in Berlin, and colleagues assessed patients with early progressive rheumatoid arthritis who were methotrexate-naïve and randomly assigned to 104 weeks of double-blind placebo plus methotrexate, 8 mg/kg tocilizumab plus placebo, 4...
    Read more ...